Breadcrumb Home May 02, 2013 01:00 AM AP6 probed for investing in propofol maker Blue & Green Tomorrow Tweet Share Share Email More Reprints Print Recommended for You European pension funds struggle in pursuit of returns, doing good Stocks, bonds help plans deliver robust returns – Wilshire TUCS MassPRIM surpasses benchmark with 30% gross annual return Sponsored Content: Private Markets 2021 sponsored Events Sponsored White Papers Guaranteed Retirement Income: Appropriate Considerations for ERISA Plan Fiducia… From Alternative to Mainstream Bond Compass - Catching Yield Waves this Summer Essential Housing: Resiliency in a time of scarcity – a unique approach to the … Evolving Forces: Convergence in the U.S. Retirement Marketplace Fire or Hire: How patient should you be when your manager is underperforming? View More Sponsored Content Partner Content The Industrialization of ESG Investment For institutional investors, ETFs can make meeting liquidity needs easier Gold: the most effective commodity investment 2021 Investment Outlook | Investing Beyond the Pandemic: A Reset for Portfolios Ten ways retirement plan professionals add value to plan sponsors Gold: an efficient hedge View More
